Healthcare Global Enterprises Limited
Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.
What Healthcare files
- Others94
- Investor Meet28
- Important24
- Updates21
- Board Meeting14
- PPTs10
HCG delivered robust Q1 FY27 results, with revenue up 13% YoY to ₹695.1 Cr and Adjusted EBITDA growing 20% YoY to ₹133.9 Cr, pushing margins to 19.4%. Profit after Tax surged 190% YoY to ₹13.8 Cr, with EPS at ₹0.92. Patient volumes increased 11%, driving broad-based growth across South (+16%),...
HealthCare Global Enterprises (HCG) posted solid Q4 and FY26 results. **Business Performance:** Q4 revenue grew 11% YoY to ₹652.3 Cr, while FY26 revenue rose 15% YoY to ₹2,545.4 Cr. Adjusted EBITDA for FY26 increased 19% YoY to ₹471.1 Cr, with margins expanding to 18.5%. Growth was broad-based, with West, South,...
Here's a concise, retail-friendly summary: **1. Business Performance:** HCG posted robust Q3FY26 revenue, up 13% YoY to ₹633.1 Cr. Excl. fertility, revenue grew via 8% higher volumes & 5% ARPP. West cluster revenue rose 17% YoY, with international business surging 42%. 9MFY26 overall revenue was up 16% to ₹1,893.1 Cr....
**Business Performance:** HealthCare Global Enterprises (HCG) delivered robust Q3 performance, with revenue up 13% YoY to 633.1 Cr, fueled by 8% volume growth and a 5% rise in Average Revenue Per Patient (ARPP, excluding fertility). For the nine-month period (9MFY26), revenue increased 15% YoY to 1,893.1 Cr. Growth was broad-based...
HCG, India's largest oncology-focused hospital chain, is redefining cancer care. **Business Performance:** HCG delivered robust financial performance with FY25 revenue at **2,222.8 Cr** and Adjusted EBITDA at **396.3 Cr**. For Q2 FY26, revenue jumped 18% YoY to **632.1 Cr**, and H1 FY26 saw a 17% YoY rise to **1,230.3 Cr**....